FI922235A0 - Foerfarande foer framstaellning av 3-aminopyridazinderivat, som verkar pao det centrala nervsystemet. - Google Patents

Foerfarande foer framstaellning av 3-aminopyridazinderivat, som verkar pao det centrala nervsystemet.

Info

Publication number
FI922235A0
FI922235A0 FI922235A FI922235A FI922235A0 FI 922235 A0 FI922235 A0 FI 922235A0 FI 922235 A FI922235 A FI 922235A FI 922235 A FI922235 A FI 922235A FI 922235 A0 FI922235 A0 FI 922235A0
Authority
FI
Finland
Prior art keywords
image
nervsystemet
aminopyridazinderivat
pao
foerfarande foer
Prior art date
Application number
FI922235A
Other languages
English (en)
Other versions
FI922235A (fi
Inventor
Jean-Jacques Bourguignon
Jean-Paul Kan
Camille George Wermuth
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of FI922235A0 publication Critical patent/FI922235A0/fi
Publication of FI922235A publication Critical patent/FI922235A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI922235A 1991-05-16 1992-05-15 Foerfarande foer framstaellning av 3-aminopyridazinderivat, som verkar paodet centrala nervsystemet FI922235A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105973A FR2676444B1 (fr) 1991-05-16 1991-05-16 Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.

Publications (2)

Publication Number Publication Date
FI922235A0 true FI922235A0 (fi) 1992-05-15
FI922235A FI922235A (fi) 1992-11-17

Family

ID=9412856

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922235A FI922235A (fi) 1991-05-16 1992-05-15 Foerfarande foer framstaellning av 3-aminopyridazinderivat, som verkar paodet centrala nervsystemet

Country Status (23)

Country Link
US (1) US5276036A (fi)
EP (1) EP0514277B1 (fi)
JP (1) JPH0673021A (fi)
KR (1) KR920021517A (fi)
AT (1) ATE115569T1 (fi)
AU (1) AU656770B2 (fi)
BR (1) BR9201854A (fi)
CA (1) CA2068770A1 (fi)
CZ (1) CZ282531B6 (fi)
DE (1) DE69200895T2 (fi)
DK (1) DK0514277T3 (fi)
ES (1) ES2065755T3 (fi)
FI (1) FI922235A (fi)
FR (1) FR2676444B1 (fi)
GR (1) GR3015389T3 (fi)
HU (2) HUT61305A (fi)
IE (1) IE66926B1 (fi)
IL (1) IL101885A (fi)
MX (1) MX9202282A (fi)
NO (1) NO180233C (fi)
NZ (1) NZ242760A (fi)
RU (1) RU2088577C1 (fi)
TW (1) TW227997B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656631A (en) * 1989-02-07 1997-08-12 Sanofi Pyridazine derivatives
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
JP2983141B2 (ja) * 1993-10-06 1999-11-29 株式会社三和化学研究所 新規化合物及び該化合物を有効成分とする脳機能改善剤
GB9707693D0 (en) * 1997-04-16 1997-06-04 Smithkline Beecham Plc Novel method of treatment
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
MXPA02011631A (es) * 2000-05-26 2003-03-27 Pfizer Derivados de tropano utiles en terapia.
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
US8265724B2 (en) * 2007-03-09 2012-09-11 Nellcor Puritan Bennett Llc Cancellation of light shunting
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
WO2011133920A1 (en) 2010-04-23 2011-10-27 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
CN111499615B (zh) * 2017-08-04 2024-02-02 斯基霍克疗法公司 用于调节剪接的方法和组合物
WO2019152809A1 (en) * 2018-02-02 2019-08-08 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor m4
CN118812532A (zh) 2019-02-05 2024-10-22 斯基霍克疗法公司 用于调节剪接的方法和组合物
JP2022519311A (ja) * 2019-02-05 2022-03-22 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
KR20210123344A (ko) * 2019-02-05 2021-10-13 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
CN113677342A (zh) * 2019-02-05 2021-11-19 斯基霍克疗法公司 用于调节剪接的方法和组合物
KR20210135507A (ko) 2019-02-06 2021-11-15 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
AR119731A1 (es) 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3
US11129829B2 (en) 2019-06-17 2021-09-28 Skyhawk Therapeutics, Inc. Methods for modulating splicing
WO2022166890A1 (zh) * 2021-02-08 2022-08-11 南京明德新药研发有限公司 取代的哒嗪苯酚类衍生物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
FR2665442B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
PT93060B (pt) * 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines

Also Published As

Publication number Publication date
HU9201626D0 (en) 1992-08-28
CA2068770A1 (en) 1992-11-17
DE69200895T2 (de) 1995-06-29
DE69200895D1 (de) 1995-01-26
NO921949D0 (no) 1992-05-15
AU656770B2 (en) 1995-02-16
FR2676444A1 (fr) 1992-11-20
CZ147392A3 (en) 1993-03-17
CZ282531B6 (cs) 1997-08-13
EP0514277B1 (fr) 1994-12-14
ES2065755T3 (es) 1995-02-16
KR920021517A (ko) 1992-12-18
NO921949L (no) 1992-11-17
IE66926B1 (en) 1996-02-07
HU211920A9 (en) 1996-01-29
FR2676444B1 (fr) 1995-03-10
GR3015389T3 (en) 1995-06-30
NO180233B (no) 1996-12-02
MX9202282A (es) 1992-12-01
DK0514277T3 (da) 1995-05-01
NO180233C (no) 1997-03-12
IE921557A1 (en) 1992-11-18
HUT61305A (en) 1992-12-28
NZ242760A (en) 1994-12-22
BR9201854A (pt) 1993-01-05
TW227997B (fi) 1994-08-11
EP0514277A1 (fr) 1992-11-19
IL101885A0 (en) 1992-12-30
IL101885A (en) 1996-08-04
RU2088577C1 (ru) 1997-08-27
ATE115569T1 (de) 1994-12-15
US5276036A (en) 1994-01-04
AU1627492A (en) 1992-11-19
FI922235A (fi) 1992-11-17
JPH0673021A (ja) 1994-03-15

Similar Documents

Publication Publication Date Title
FI922235A0 (fi) Foerfarande foer framstaellning av 3-aminopyridazinderivat, som verkar pao det centrala nervsystemet.
CO5280078A1 (es) Compuestos
AR038433A2 (es) Derivados 2-alquil-2-desoxo de parahercuamida y marcfortina
NO20015669D0 (no) Heterocykliske substituerte aminoazacykler nyttige som sentralnervesystemmidler
ES2142773A1 (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
DK0947504T3 (da) 16-en-vitamin D-derivater
MX9203360A (es) Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen.
NO921159D0 (no) Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer
ES2093091T3 (es) Derivado de glutation.
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
ES2140524T3 (es) Derivados de metotrexato.
NZ513203A (en) Pyrrolo [2,1-c][1,2,4] benzothiadiazine compounds and pharmaceutical use as AMPA modulators
ATE192141T1 (de) Aromatische hydroxamsäure-verbindungen, ihre herstellung und verwendung
ES2111768T3 (es) Derivados de carboestirilo utilizados como agentes antiarritmicos.
ES2098517T3 (es) Derivados de 1,2,4-tiadiazino(3,4-b)benzotiazol, su preparacion y los medicamentos que los contienen.
TR199701289T2 (xx) Karbapenemlerin esterleri
DE69301639D1 (de) Tetrahydronaphtalenderivate, ihre Herstellung und ihre therapeutische Verwendung
KR920002613A (ko) 이환성 함유 황화합물

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: SANOFI